
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NEDD4-L CRISPR/Cas9 KO Plasmid (m) | sc-429949 | 20 µg | $397.00 |
Nedd4l encodes NEDD4-L, a HECT-domain E3 ubiquitin ligase that regulates protein turnover by catalyzing ubiquitination of membrane and signaling proteins, including ion channels and transporters such as ENaC. Through modulation of ubiquitin-dependent endocytosis and lysosomal/proteasomal degradation, NEDD4-L influences epithelial ion homeostasis and signal transduction pathways implicated in cellular stress responses and tissue remodeling. In mouse systems, altered Nedd4l activity has been linked to dysregulated sodium handling and blood pressure control, and has been investigated in contexts of renal physiology, cardiovascular phenotypes, and inflammatory signaling. NEDD4-L also interfaces with pathways controlling cell polarity and differentiation, making it relevant for studies of epithelial barrier function and developmental processes.
NEDD4-L CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Nedd4l gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Nedd4l together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Nedd4l open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish NEDD4-L protein expression.
This CRISPR knockout system enables efficient generation of Nedd4l-deficient cell models for investigation of NEDD4-L signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.